Evidence map›Paper›PMID 40924934›Full record

ReviewThe Biochemical journal2025

RNMT-dependent RNA cap methylation in health and disease.

Jacquie G Mills, Lydia A Hepburn, Victoria H Cowling

Abstract readReview
In one paragraph

Review in The Biochemical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jacquie G MillsCancer Research UK Scotland Institute, Glasgow, G61 1BD, U.K.
Lydia A HepburnCancer Research UK Scotland Institute, Glasgow, G61 1BD, U.K.
Victoria H CowlingCancer Research UK Scotland Institute, Glasgow, G61 1BD, U.K.ORCID 0000-0001-7638-4870

Funding

Wellcome Trust
6 · The paper itself

Abstract

RNA cap formation on RNA polymerase II transcripts is regulated by cellular signalling pathways during development and differentiation, adaptive and innate immune responses, during the cell cycle and in response to oncogene deregulation. Here, we discuss how the RNA cap methyltransferase, RNA guanine-7 methyltransferase (RNMT), functions to complete the 7-methyl-guanosine or m7G cap. The mechanisms by which RNMT is regulated by signalling pathways, co-factors and other enzymes are explored. The m7G cap protects RNA pol II-transcribed RNA from the initiation of transcription and recruits proteins that mediate RNA processing including splicing, 3' cleavage and polyadenylation, nuclear export and translation initiation. Regulation of RNMT has gene-specific impacts with implications for cell function, cell physiology and cell fate decisions.

Indexed as

MethyltransferasesRNA CapsAnimalsHumansMethylationSignal TransductionMethyltransferasesmRNA (guanine(N7))-methyltransferaseRNA Capsgene regulationRNARNA methylationRNA processingtranscriptiontranslation

Identifiers

PMID40924934
PMCPMC12599247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.